Clearside Biomedical, Inc.
Pharmaceutical Preparations · ALPHARETTA
High confidence (85%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Clearside Biomedical, Inc. deregistered its securities (Jan 7, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Clearside Biomedical, Inc. deregistered its securities
Jan 7, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 d57537d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37783 Clearside Biomedical, Inc. (Exact name of registrant as specified in its charter) 900 North Point Parkway, Suite 200 Alpharetta, Georgia 30005 (678) 270-3631 (Address, including zip code, and telephone number, including area c…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker CLSDQ on OTC.
- SEC CIK
- 0001539029
- Website
- —
- —
- Headquarters
- ALPHARETTA
- Also known as
- —
- Legal entities
- Clearside Biomedical, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Clearside Biomedical, Inc. — Pharmaceutical Preparations (SIC 2834) — ALPHARETTA, GA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 d57537d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37783 Clearside Biomedical, Inc. (Exact name of registrant as specified in its charter) 900 North Point Parkway, Suite 200 Alpharetta, Georgia 30005 (678) 270-3631 (Address, including zip code, and telephone number, including area c…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:32 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:14 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.